CLINICAL_TRIALS
trial_result
· 2020-12-17
Clinical Trial Update: Oral Anticoagulation Therapy Pilot Study [Phase 4]
Summary
A Phase 4 trial of an oral anticoagulation therapy for paroxysmal atrial fibrillation was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosense Webster, Inc. | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: TERMINATED | Results posted: 2020-12-17